Author: Syed Faraz Ahmed; Ahmed A. Quadeer; Matthew R. McKay
Title: Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies Document date: 2020_2_4
ID: 7i52vltp_7
Snippet: Here, by analysing available experimentally-determined SARS-CoV-derived B cell epitopes (both linear and discontinuous) and T cell epitopes, we identify and report those that are completely identical and comprise no mutation in the available SARS-CoV-2 sequences (as of 9 February 2020). These epitopes have the potential, therefore, to elicit a cross-reactive/effective response against SARS-CoV-2. We focused particularly on the epitopes in the S a.....
Document: Here, by analysing available experimentally-determined SARS-CoV-derived B cell epitopes (both linear and discontinuous) and T cell epitopes, we identify and report those that are completely identical and comprise no mutation in the available SARS-CoV-2 sequences (as of 9 February 2020). These epitopes have the potential, therefore, to elicit a cross-reactive/effective response against SARS-CoV-2. We focused particularly on the epitopes in the S and N structural proteins due to their dominant and longlasting immune response previously reported against SARS-CoV. For the identified T cell epitopes, we additionally incorporated the information about the associated MHC alleles to provide a list of epitopes that seek to maximize population coverage globally, as well as in China. Our presented results can potentially narrow down the search for potent targets for an effective vaccine against SARS-CoV-2, and help guide experimental studies focused on vaccine development.
Search related documents:
Co phrase search for related documents- associated MHC allele and population coverage: 1, 2
- associated MHC allele and population coverage maximize: 1
- associated MHC allele information and MHC allele: 1, 2
- associated MHC allele information and population coverage: 1, 2
- associated MHC allele information and population coverage maximize: 1
- available SARS sequence and cell epitope: 1
- available SARS sequence and population coverage: 1
- available SARS sequence and SARS report: 1, 2
- available SARS sequence and SARS sequence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- available SARS sequence and structural protein: 1
- available SARS sequence and vaccine development: 1, 2
Co phrase search for related documents, hyperlinks ordered by date